Cadrenal Therapeutics, Inc. /
eXIthera Pharmaceuticals, Inc.
Cadrenal Therapeutics, Inc. agrees to buy eXIthera Pharmaceuticals, Inc.
Source for the buyer and target: Cadrenal Therapeutics, Inc.
For the buyer and target.
“Purchase Agreement between Cadrenal Therapeutics, Inc. and eXIthera Pharmaceuticals, Inc.”
Published 15 Sep 2025
Open the sourceWhat happened
Cadrenal Therapeutics, Inc. agreed to acquire eXIthera Pharmaceuticals, Inc. for not to exceed $15 million, according to a filing dated Sept. 15, 2025. [01]
The source
Everything on this page comes from the source below, quoted word for word.
Cadrenal Therapeutics, Inc. agrees to buy eXIthera Pharmaceuticals, Inc.
This document is the source for the companies, stage, figure and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
Announced
“Cadrenal Therapeutics, Inc. agrees to buy eXIthera Pharmaceuticals, Inc. Cadrenal Therapeutics, Inc. agreed to acquire eXIthera Pharmaceuticals, Inc. for not to exceed $15 million, according to a filing dated Sept. 15…”
Open the source
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
By email · Weekly